Tue, December 7, 2010
Mon, December 6, 2010
Fri, December 3, 2010
Thu, December 2, 2010
Wed, December 1, 2010
Tue, November 30, 2010
[ Tue, Nov 30th 2010 ] - Market Wire
2005 Certification
Mon, November 29, 2010
Thu, November 25, 2010
Wed, November 24, 2010
Tue, November 23, 2010
Mon, November 22, 2010
Sat, November 20, 2010
Fri, November 19, 2010
Thu, November 18, 2010
Wed, November 17, 2010
Tue, November 16, 2010
Mon, November 15, 2010
Sun, November 14, 2010
Fri, November 12, 2010
Thu, November 11, 2010

Anika Therapeutics to Present at NYSSA Biotech and Specialty Pharmaceuticals Conference


//health-fitness.news-articles.net/content/2010/ .. ch-and-specialty-pharmaceuticals-conference.html
Published in Health and Fitness on Tuesday, November 23rd 2010 at 6:05 GMT by Market Wire   Print publication without navigation


BEDFORD, Mass.--([ BUSINESS WIRE ])--Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that Kevin Quinlan, chief financial officer, will be presenting at the New York Society of Security Analysts (NYSSA) Biotech and Specialty Pharmaceuticals Conference on Tuesday, November 30, 2010. A live audio webcast of the 2:05 p.m. (ET) presentation may be accessed via the aInvestorsa section of Anikaa™s website at [ www.anikatherapeutics.com ]. An archive of the presentation also will be available on the website. At the conference, Mr. Quinlan will discuss the companya™s business highlights, including the integration of its FAB acquisition.

About Anika Therapeutics, Inc.

Headquartered in Bedford, Mass., [ Anika Therapeutics, Inc ]. develops, manufactures and commercializes therapeutic products for tissue protection, healing, repair and regeneration. These products are based on [ hyaluronic acid (HA) ], a naturally occurring, biocompatible polymer found throughout the body. Anikaa™s products range from orthopedic/joint health solutions led by [ ORTHOVISC ]®, a treatment for osteoarthritis of the knee; to surgical aids in the [ ophthalmic ] and [ anti-adhesion ] fields. The company also offers [ aesthetic dermal fillers ] for the correction of facial wrinkles. Anikaa™s Italian subsidiary, Fidia Advanced Biopolymers, S.r.l (FAB), provides complementary HA products in orthopedic/joint health and anti-adhesion, as well as therapeutics in new areas such as advanced wound treatment and ear, nose and throat care. FABa™s regenerative tissue technology advances Anikaa™s vision to offer therapeutic products that go beyond pain relief to protect and restore damaged tissue.


Publication Contributing Sources